Point-Counterpoint

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 1-10 of 12 total displayed.

Most recent content

Point/Counterpoint
Folic Acid Supplementation and Cancer Risk: Point

Young-In Kim
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 2220-2225. [Full text] [PDF]  

Point/Counterpoint
Folate and Cancer Prevention—Where to Next? Counterpoint

Cornelia M. Ulrich
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 2226-2230. [Full text] [PDF]  

Past content

Point/Counterpoint
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Point

Nadir Arber
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1852-1857. [Abstract] [Full text] [PDF]  

Point/Counterpoint
Cyclooxygenase-2 Inhibitors in Colorectal Cancer Prevention: Counterpoint

Janusz Jankowski and Richard Hunt
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1858-1861. [Abstract] [Full text] [PDF]  

Point/Counterpoint
Aspirin is Clinically Effective in Chemoprevention of Colorectal Neoplasia: Point

Moshe Leshno, Menachem Moshkowitz, and Nadir Arber
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1558-1561. [Full text] [PDF]  

Point/Counterpoint
Aspirin Should Not Be Promoted for Colon Cancer Prevention: Counterpoint

Robert S. Sandler
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1562-1563. [Full text] [PDF]  

Point/Counterpoint
The Case for a Gender-Neutral (Universal) Human Papillomavirus Vaccination Policy in the United States: Point

Anna R. Giuliano and Daniel Salmon
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 805-808. [Full text] [PDF]  

Point/Counterpoint
Human Papillomavirus Vaccination Should Be Offered to Young Males: Counterpoint

Cornelia L. Trimble
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 809. [Full text] [PDF]  

Point/Counterpoint
Tamoxifen or Raloxifene for Breast Cancer Chemoprevention: A Tale of Two Choices—Point

V. Craig Jordan
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2207-2209. [Full text] [PDF]  

Point/Counterpoint
Tamoxifen or Raloxifene in Postmenopausal Women for Prevention of Breast Cancer: A Tale of Two Choices—Counterpoint

Carol Fabian
Cancer Epidemiol. Biomarkers Prev. 2007; 16: 2210-2212. [Full text] [PDF]  

[Next page] Pages: 1 2